Trial of Sertraline to Treat Children With Fragile X Syndrome

Summary

This study is a control trial of sertraline (Zoloft) in fragile X syndrome children aged 2 years to 5 years 8 months old. The trial is six months long, and each participant will receive a series of tests at both the beginning and end of the study. The researchers hope to show improvements in language and a decrease in autistic symptoms.

Timeline

Start

2012-01

Primary completion

2015-08

Completion

2015-09

Drugs

Indications